Publication | Open Access
Exposure to valproic acid is associated with less pulmonary infiltrates and improvements in diverse clinical outcomes and laboratory parameters in patients hospitalized with COVID-19
11
Citations
26
References
2022
Year
VPA-treated patients seem to develop less serious COVID-19 than control patients, according to diverse clinical endpoints and laboratory markers.
| Year | Citations | |
|---|---|---|
Page 1
Page 1